q

Symposium Postponed

Due to the COVID-19 outbreak the 8th Fernö Breast Cancer Symposium will be postponed until next year - autumn 2021

The 8th Fernö Breast Cancer Symposium

Age-related aspects of breast cancer

E

Program

Preliminary program 8th Fernö Breast Cancer symposium.

E

Invited Speakers

Speakers and universities.

E

Submit Abstract

Use these guidelines.

E

Partners

Supported by The Swedish Breast Cancer Association
and the Swedish Cancer Society.

Preliminary Program

Welcome to the 8th Fernö Breast Cancer Symposium, 8th – 9th October 2020 at Wärdshuset Lasse Maja, Stockholm Järfälla

 

Registration date:  2020-06-09 

Late registration date:  2020-09-01

Abstract submission date:  2020-09-01

Use these guidelines: Download Abstract Submission Guidelines

Early registration:  2.900 SEK (excl VAT)

Late registration:  3.700 SEK (excl VAT)

The Swedish Translational Research in Breast Cancer (Swe-TRIBE) group is a national group of translational researchers all working within the field of breast cancer. The aim of Swe-TRIBE is to stimulate translational breast cancer research across Sweden with the ultimate aim of paving the way for clinical implementation of research findings. The Swedish Cancer Society financially supports the work of Swe-TRIBE.

Swe-TRIBE organizes an annual translational symposium. We encourage junior and senior researchers to join as participants at the symposium to create a fruitful environment. This is a great opportunity to present your research as well as meeting and interacting with other researchers working within the breast cancer field. This year we again have the honour to welcome a plethora of distinguished speakers. Please see this year’s program below.

Thursday October 8

09:00–10:00  Registration and coffee

10:00–10:15  Welcome and introduction: Linda Lindström and Sophia Zackrisson, Chairmen Swe-TRIBE

Session 1 | Epidemiological challenges

10:15–10:55  KEYNOTE: Epidemiological challenges in understanding the impact of age on risk, incidence, mortality in breast cancer | Lars Holmberg

11:00–11:40  KEYNOTE: What are the main problems in younger vs older women from a clinical perspective? | Speaker TBA

Session 2 | Molecular aspects

11:45–12:25  KEYNOTE: Molecular aspects, tumor biology and age| Speaker TBA

12:30-13:30  Lunch

Session 3 | Age-individualized rehabilitation in breast cancer

13:30–13:55  Individualized rehabilitation after primary breast cancer surgery | Marlene Malmström

14:00–14:25  Patient perspective | Susanne Dieroff-Hay, Bröstcancerförbundet

Selected Oral Presentations

14:30–15:30

15:30–16:00  Coffee

Workshop

16:00–17:30

17:30–18:15  Free time

Poster mingle’n drinks (2-min-presentations)

18:00–19:00

19:15  Dinner

Friday October 9

Session 4 | Treatment and clinical aspects

08:30–08:55  Fertility preservation after breast cancer| Speaker TBA

09:00–09:25  Breast cancer treatment in elderly | Barbro Linderholm

09:30–09:55  Radiation therapy in older women| Speaker TBA

10:00–10:30  Coffee break

Session 5 | Age of the tumor – molecular/biological aspects

10:30–10:55  Molecular and genetic perspectives| Speaker TBA

11:00–11:25  Pregnancy-related breast cancer| Speaker TBA

11:30–11:55  Biology, long term risk and tumor dormancy| Speaker TBA

12:00–12:15  Summary and thank you

12:15–13:15  Lunch

 

Invited Speakers

Lars Holmberg

Marlene Malmström

Susanne Dieroff-Hay

Barbro Linderholm

More to be announced